Mannkind (MNKD) EBIT Growth (1y) (2011 - 2026)
Mannkind (MNKD) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -107.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -107.48% |
| Dec 31, 2025 | -129.01% |
| Sep 30, 2025 | 48.09% |
| Jun 30, 2025 | -68.10% |
| Mar 31, 2025 | 33.32% |
| Dec 31, 2024 | 237.17% |
| Sep 30, 2024 | 150.34% |
| Jun 30, 2024 | 865.14% |
| Mar 31, 2024 | 378.79% |
| Dec 31, 2023 | 161.44% |
| Sep 30, 2023 | 153.04% |
| Jun 30, 2023 | 108.41% |
| Mar 31, 2023 | 71.78% |
| Dec 31, 2022 | 46.64% |
| Sep 30, 2022 | -45.83% |
| Jun 30, 2022 | -99.10% |
| Mar 31, 2022 | -243.34% |
| Dec 31, 2021 | -0.93% |
| Sep 30, 2021 | 27.82% |
| Jun 30, 2021 | -29.79% |